Articles Referencing HSP

Zacks.com

Earnings Beat at Hospira - Analyst Blog

Hospira Inc. 's ( HSP ) first quarter 2013 adjusted earnings of 52 cents per share beat the Zacks Consensus Estimate of 44 cents. Higher-than-expected revenues led to the earnings beat.... Read >>

GuruFocus

Brian Rogers of T Rowe Price Buys 4 New Stocks, Including Apple in Q1

In the quarter ended March 31, 2013, T. Rowe Price's Brian Rogers purchased three new stocks for his fund: Apple ( AAPL ), Western Union ( WU ), Joy Global ( JOY ) and Hospira Inc. ( ... Read >>

Zacks.com

Bear of the Day: Hospira (HSP) - Bear of the Day

Hospira has been facing some serious manufacturing quality concerns related its injectable drugs as well as infusion pump systems. Its remediation efforts may be successful in the long-run but... Read >>

Zacks.com

Pediatric Exclusivity for Hospira's Drug - Analyst Blog

Hospira, Inc. ( HSP ) recently gained pediatric exclusivity from the US Food and Drug Administration (FDA) for its injectable sedation drug, Precedex (dexmedetomidine HCl). The FDA's... Read >>

Zacks.com

Bearish MACD for Hospira, Inc. - Tale of the Tape

Hospira, Inc. 's ( HSP ) MACD indicator has moved into bearish territory with a reading of -1.1286. The Zacks Rank # 5 ("Strong Sell") stock decreased more than 0.60% to $29.59 in... Read >>

Zacks.com

Blow for HSP, 2013 View Withdrawn - Analyst Blog

Hospira Inc. 's ( HSP ) shares fell significantly following the import ban imposed by the US Food and Drug Administration (FDA) on some of the company's offerings. Hospira withdrew its... Read >>

NASDAQ.com News

Pre-Market Earnings Report for February 13, 2013 : CMCSA, DUK, DE, TRI, CMCSK, LO, TLM, DPS, CPN, HSIC, HSP, VMI

The following companies are expected to report earnings prior to market open on 02/13/2013. Visit our Earnings Calendar for a full list of expected earnings releases. Comcast Corporation ( ... Read >>

Zacks.com

Hospira Inks Deal - Analyst Blog

Hospira, Inc. ( HSP ) recently inked a deal with medical devices company Q Core Medical, Ltd. pertaining to the latter's Q Core Sapphire multi-therapy infusion system. The system is a... Read >>

Zacks.com

Hospira Downgraded to Strong Sell - Analyst Blog

On January 2, Zacks Investment Research downgraded Hospira, Inc. ( HSP ) to a Zacks #5 Rank (Strong Sell). Why the Downgrade? Hospira is going through a rough patch due to the... Read >>

Kapitall

Reuters Survey: Investors Expect a Big Stock Market Rally in 2012

(Written by Alexander Crawford, list compiled by Eben Esterhuizen, CFA. Short data sourced from Yahoo! Finance.) It seems that fears of a double-dip recession and a potentially contagious... Read >>

David Sterman

The 2 Best Stocks for this $33 Billion Trend

For the millions of Americans who suffer from high cholesterol, Nov. 30 will be a big day. That's when Pfizer's (NYSE: PFE ) blockbuster drug Lipitor will lose patent protection,... Read >>

Kapitall

Healthcare Takeovers Targets: Express Scripts Buys Medco

( List compiled by Becca Lipman ) The two largest US pharmacy benefit managers are combining forces: Express Scripts ( ESRX ) will buy Medco Health Solution ( MHS ) for about $29 billion... Read >>

SeekingAlpha

A Closer Look at the Biovail - Valeant Merger

EP Vantage submits: The proposed $3.2bn merger between Canadian Biovail ( BVF ) and Valeant Pharmaceuticals International ( VRX ) of the U.S. should not only create a bigger,... Read >>

David Sterman

Tuesday Winners: Durect, A123 Systems and Gammon Gold

Among the biggest winners in Tuesday's early trading are Durect (Nasdaq: DRRX) , A123 Systems (Nasdaq: AONE) and Gammon Gold ( GRS ) . Top... Read >>

Louis Navellier

5 Booming Blue Chip Stocks to Buy Now

5 Top Small Cap Stocks 5 Top Blue Chip Stocks to Buy Now The stock market wasn't kind to investors in May, with the major indexes taking a tumble. But if you think this... Read >>

Displaying 1-15 of 16
<< first < previous 1 2 next > last >>